Male Breast Cancer Completed Phase 1 / 2 Trials for Indoximod (DB12827)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01042535Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast CancerTreatment